Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLWB.L Regulatory News (LWB)

  • There is currently no data for LWB

Form 8.3 - Low & Bonar PLC

2 Oct 2019 13:52

RNS Number : 5437O
Weiss Asset Management LP
02 October 2019
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund)

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Low & Bonar PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

30 September 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

Β 

5p ordinary - 689,756,295

(ISIN: GB0005363014)

Β 

Interests

Β 

Short Positions

Β 

Β 

Β 

Number

Β 

%

Β 

Number

Β 

%

Β 

(1) Relevant securities owned and/or controlled:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(2) Cash-settled derivatives:

Β 

7,300,000

Β 

1.06 %

Β 

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

7,300,000

Β 

1.06 %

Β 

Β 

Β 

Β 

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Β 

Purchase/Sale

Β 

Number of securities

Β 

Price per unit

Β 

N/A

Β 

N/A

Β 

N/A

Β 

N/A

Β 

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Β 

Product description e.g. CFD

Β 

Nature of dealing e.g. Opening/Closing a long/short position, increasing/reducing a long/short position

Β 

Number of reference securities

Β 

Price per unit

Β 

5p ordinary

CFD

Β 

increasing a long position

Β 

2,900,000

Β 

GBP .146431

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

No

Β 

Β 

Date of disclosure:

02 October 2019

Contact name:

Georgiy Nikitin

Telephone number:

+1-617-778-7780

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
RETLLFSFIALFIIA
Date   Source Headline
1st Jun 20172:36 pmRNSHolding(s) in Company
31st May 20177:00 amRNSTotal Voting Rights
16th May 20173:16 pmRNSRe: Board Change
18th Apr 20177:05 amRNSAppointment of Chief Financial Officer
12th Apr 201712:20 pmRNSResult of AGM
12th Apr 20177:00 amRNSTrading Update
5th Apr 20178:00 amRNSBlock Listing Application
31st Mar 20177:00 amRNSTotal Voting Rights
29th Mar 201711:35 amRNSDirector/PDMR Shareholding
28th Mar 201710:13 amRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSDirector/PDMR Shareholding
20th Mar 201710:07 amRNSHolding(s) in Company
3rd Mar 20172:37 pmRNSHolding(s) in Company
1st Mar 201712:00 pmRNSDirector Declaration
1st Mar 20177:00 amRNSDirectorate Change
27th Feb 201712:00 pmRNSAnnual Financial Report
1st Feb 201711:34 amRNSTotal Voting Rights
1st Feb 20177:00 amRNSFinal Results
16th Jan 201712:07 pmRNSSecond Price Monitoring Extn
16th Jan 201712:02 pmRNSPrice Monitoring Extension
9th Jan 20177:00 amRNSNotice of Results
5th Jan 20174:40 pmRNSSecond Price Monitoring Extn
5th Jan 20174:35 pmRNSPrice Monitoring Extension
4th Jan 201712:16 pmRNSHolding(s) in Company
4th Jan 201712:14 pmRNSHolding(s) in Company
3rd Jan 20172:27 pmRNSTotal Voting Rights
14th Dec 201610:43 amRNSHolding(s) in Company
1st Dec 201610:22 amRNSTotal Voting Rights
23rd Nov 20163:51 pmRNSDirector/PDMR Shareholding
22nd Nov 20162:56 pmRNSDirector/PDMR Shareholding
22nd Nov 20162:55 pmRNSDirector/PDMR Shareholding
11th Nov 20167:00 amRNSAppointment of Non-executive Director
9th Nov 201612:07 pmRNSSecond Price Monitoring Extn
9th Nov 201612:02 pmRNSPrice Monitoring Extension
3rd Nov 20167:00 amRNSTrading Update
1st Nov 20169:21 amRNSTotal Voting Rights
3rd Oct 201610:03 amRNSHolding(s) in Company
3rd Oct 20169:00 amRNSTotal Voting Rights
23rd Sep 201612:07 pmRNSSecond Price Monitoring Extn
23rd Sep 201612:02 pmRNSPrice Monitoring Extension
19th Sep 201612:07 pmRNSSecond Price Monitoring Extn
19th Sep 201612:02 pmRNSPrice Monitoring Extension
5th Sep 20163:31 pmRNSDirector/PDMR Shareholding
5th Sep 20162:38 pmRNSTotal Voting Rights
2nd Sep 20167:00 amRNSCompletion of Disposal
1st Sep 20164:42 pmRNSHolding(s) in Company
3rd Aug 201612:32 pmRNSDirector/PDMR Shareholding
2nd Aug 20162:57 pmRNSTotal Voting Rights
21st Jul 20164:40 pmRNSSecond Price Monitoring Extn
21st Jul 20164:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.